Read the corresponding article: https://peptideresearch.us/retatrutide-and-body-composition/

Click here to join our Discord: Real Peptide Talk

Shop Research Compounds: https://wholesalepeptides.us

Visit our blog: https://peptideresearch.us

Join our Newsletter list: https://peptideresearch.us/newsletter

In this episode, we explore the science behind Retatrutide, often referred to as GLP-3, and its growing significance in metabolic research. As the focus of scientific investigation shifts from simple weight reduction to comprehensive body composition, this compound has rapidly become a major topic of discussion. We introduce the core concepts of this next-generation peptide and examine why researchers are so interested in its unique properties.

Retatrutide stands out from earlier metabolic compounds due to its triple agonist design, which targets GLP-1, GIP, and glucagon receptors simultaneously. This broader signaling profile allows scientists to study a wider range of metabolic mechanisms, including energy expenditure, metabolic flexibility, and nutrient handling. The addition of glucagon receptor activation has generated particular interest among researchers regarding how interconnected pathways may influence fat mass reduction while helping to preserve critical lean muscle tissue in laboratory models.

Listeners will learn exactly how Retatrutide differs from single and dual-agonist compounds like semaglutide and tirzepatide. We break down the primary functions of all three signaling pathways and explain why measuring body composition—specifically the balance of visceral fat, subcutaneous fat, and lean mass—is far more informative for researchers than tracking overall weight. Join us to understand the mechanisms behind GLP-3 and what the scientific community is focusing on next in the evolution of metabolic studies.